Anita Kumar, MD
Memorial Sloan Kettering Cancer Center · George Washington University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Anita Kumar, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:31 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06192888 · A Study of Glofitamab and Lenalidomide in People With Mantle Cell LymphomaMemorial Sloan Kettering Cancer Center · active not recruiting · Mantle Cell Lymphoma, MCL · principal investigator
- Ph2NCT05788289 · A Study of Tafasitamab and Lenalidomide in People With Mantle Cell LymphomaMemorial Sloan Kettering Cancer Center · terminated · Mantle Cell Lymphoma, MCL · principal investigator
- N/ANCT04724291 · MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients)George Washington University · completed · Abdominal Pain, Gastritis, Gastric Ulcer · principal investigator
- N/ANCT02633111 · DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin LymphomasMemorial Sloan Kettering Cancer Center · active not recruiting · B-cell Non-Hodgkin Lymphoma, Aggressive · principal investigator
- Ph2NCT02633137 · Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell LymphomaMemorial Sloan Kettering Cancer Center · completed · Mantle Cell Lymphoma, Untreated · principal investigator
- Ph1NCT02309580 · Study of Ibrutinib in Relapsed and Refractory T-cell LymphomaMemorial Sloan Kettering Cancer Center · completed · T-cell Lymphoma, Relapsed and Refractory T-cell Lymphoma · principal investigator
- N/ANCT01868451 · Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin LymphomaMemorial Sloan Kettering Cancer Center · completed · Hodgkin Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.